|
40 Companies |
|
61 Products |
|
61 Products |
|
49 Mechanisms of Action |
|
0 Trials |
|
203 News |
|
| «12345» |
- | ABT-751 / AbbVie, Eisai
Trial completion: ABT-751 in Treating Young Patients With Refractory Solid Tumors (clinicaltrials.gov) - Feb 22, 2014
P1, N=90, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
Active, not recruiting --> Completed
- | Ixempra (ixabepilone) - Otsuka, R / Pharm, patupilone (EPO 906) / Novartis
Trial completion: Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy (clinicaltrials.gov) - Feb 22, 2014
P1, N=30, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
Active, not recruiting --> Completed Recruiting --> Completed
- | Jingzhuda (entinostat) / EOC Pharma, EddingPharm
Trial completion, Epigenetic controller, Metastases: MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P1, N=75, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting --> Completed Active, not recruiting --> Completed
- | Synagis (palivizumab) / AbbVie, AstraZeneca, SOBI
Trial completion: Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | amphotericin b liposome / Generic mfg.
Trial completion: Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cisplatin / Generic mfg., temozolomide / Generic mfg.
Trial completion, Metastases: Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | temozolomide / Generic mfg.
Trial completion: Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=30, Completed, Sponsor: Duke University
Active, not recruiting --> Completed Recruiting --> Completed
- | patupilone (EPO 906) / Novartis
Trial completion, Metastases: Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Albert Einstein College of Medicine of Yeshiva University
Recruiting --> Completed Not yet recruiting --> Completed
- | captopril / Generic mfg.
Trial completion: Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation (clinicaltrials.gov) - Feb 19, 2014
P3, N=35, Completed, Sponsor: Northwestern University
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, Neumega (oprelvekin) / Astellas
Trial completion: Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | tanespimycin (BMS-722782) / BMS, NN1213 / Novo Nordisk
Trial completion, Metastases: Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | fluconazole oral / Generic mfg., itraconazole / Generic mfg.
Trial completion: Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation (clinicaltrials.gov) - Feb 19, 2014
P3, N=578, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | paclitaxel / Generic mfg., gemcitabine / Generic mfg.
Trial completion, Metastases: Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=44, Completed, Sponsor: Eastern Cooperative Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | thiotepa / Generic mfg.
Trial completion: High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=36, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Genasense (oblimersen) / Genta
Trial completion, Metastases: Chemotherapy in Treating Patients With Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=57, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | docetaxel / Generic mfg.
Trial completion, Metastases: Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: City of Hope Medical Center
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation (clinicaltrials.gov) - Feb 19, 2014
P2, N=30, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | ifosfamide / Generic mfg., cisplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion: Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=43, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: Temple University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- pemetrexed / Generic mfg., docetaxel / Generic mfg.
Enrollment closed, Combination therapy, Metastases: Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) - Feb 5, 2014
P1, N=54, Active, not recruiting, Sponsor: University of Arizona
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial termination: Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer (clinicaltrials.gov) - Jan 30, 2014
P3, N=22, Terminated, Sponsor: University of South Florida
Recruiting --> Active, not recruiting Active, not recruiting --> Terminated; The study was terminated due to slow accrual.
- Enrollment change: Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer (clinicaltrials.gov) - Jan 30, 2014
P3, N=22, Terminated, Sponsor: University of South Florida
Active, not recruiting --> Terminated; The study was terminated due to slow accrual. N=178 --> 22
- metformin / Generic mfg., carboplatin / Generic mfg., paclitaxel / Generic mfg.
New P1 trial, Biopsy: Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - Jan 28, 2014
P1, N=18, Not yet recruiting, Sponsor: Fox Chase Cancer Center
- sirolimus / Generic mfg.
Enrollment change: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (clinicaltrials.gov) - Oct 10, 2013
P1, N=30, Recruiting, Sponsor: Roswell Park Cancer Institute
N=178 --> 22 N=20 --> 30
- Enrollment change, Metastases: Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer (clinicaltrials.gov) - Oct 7, 2013
P1, N=1, Terminated, Sponsor: Stanford University
N=20 --> 30 N=14 --> 1
- Rubraca (rucaparib) / Pharma& Schweiz
Enrollment closed, BRCA Biomarker, PARP Biomarker, Metastases: CRUK-PARP/BRCA: Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer (clinicaltrials.gov) - Oct 6, 2013
P2, N=84, Active, not recruiting, Sponsor: Cancer Research UK
N=14 --> 1 Recruiting --> Active, not recruiting
- alvocidib (DSP-2033) / Sumitomo Pharma
Trial initiation date: Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors (clinicaltrials.gov) - Sep 3, 2013
P2, N=50, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Recruiting --> Active, not recruiting Initiation date: Jun 2009 --> May 2013
- Trial termination, Metastases: Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer (clinicaltrials.gov) - Aug 25, 2013
P1, N=1, Terminated, Sponsor: Stanford University
Initiation date: Jun 2009 --> May 2013 Recruiting --> Terminated; low accrual
- HEOR: Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer (clinicaltrials.gov) - Aug 20, 2013
P=N/A, N=484, Not yet recruiting, Sponsor: City of Hope Medical Center
- Neulasta (pegfilgrastim) / Roche
Enrollment closed: Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors (clinicaltrials.gov) - Aug 13, 2013
P2, N=55, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting --> Terminated; low accrual Recruiting --> Active, not recruiting
- levofloxacin / Generic mfg.
Trial completion: CRC-TU-SIGNIFICANT: Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma (clinicaltrials.gov) - Jul 31, 2013
P3, N=0, Completed, Sponsor: Cancer Research Campaign Clinical Trials Centre
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment closed: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (clinicaltrials.gov) - Jul 25, 2013
P2, N=60, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Trial completion: Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors (clinicaltrials.gov) - Jul 2, 2013
P2, N=27, Completed, Sponsor: Children's Oncology Group
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- 7-Hydroxystaurosporine (UCN-01) / National Cancer Institute
Trial completion: 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (clinicaltrials.gov) - Jun 30, 2013
P1, N=41, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors (clinicaltrials.gov) - Jun 10, 2013
P=N/A, N=64, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Active, not recruiting --> Completed N=2000 --> 64
- Trial completion: Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors (clinicaltrials.gov) - Jun 10, 2013
P=N/A, N=64, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
N=2000 --> 64 Active, not recruiting --> Completed
- ||| Enrollment open: DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings (clinicaltrials.gov) - Jun 9, 2013
P=N/A, N=932, Recruiting, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Recruiting
- Trial completion: Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy (clinicaltrials.gov) - Jun 9, 2013
P1, N=20, Completed, Sponsor: University of Louisville
Active, not recruiting --> Recruiting Recruiting --> Completed
- Trial termination, HEOR: Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer (clinicaltrials.gov) - Jun 6, 2013
P=N/A, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Recruiting --> Completed Completed --> Terminated
- Trial completion: Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer (clinicaltrials.gov) - Jun 3, 2013
P=N/A, N=70, Completed, Sponsor: Comprehensive Cancer Center of Wake Forest University
Completed --> Terminated Active, not recruiting --> Completed
- Kepivance (palifermin) / SOBI, Amgen
Enrollment change: Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant (clinicaltrials.gov) - May 29, 2013
P2, N=0, Withdrawn, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed N=200 --> 0
- | Trial completion, Trial initiation date: Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma (clinicaltrials.gov) - May 28, 2013
P=N/A, N=17, Completed, Sponsor: Children's Oncology Group
N=200 --> 0 Initiation date: Apr 2002 --> Apr 2005 | Recruiting --> Completed
- Enrollment change: Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma (clinicaltrials.gov) - May 28, 2013
P=N/A, N=17, Completed, Sponsor: Children's Oncology Group
Initiation date: Apr 2002 --> Apr 2005 | Recruiting --> Completed N=65 --> 17
- | Trial completion: Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma (clinicaltrials.gov) - May 28, 2013
P=N/A, N=17, Completed, Sponsor: Children's Oncology Group
N=65 --> 17 Recruiting --> Completed
- Torisel (temsirolimus) / Pfizer
Trial initiation date, Combination therapy, Metastases: Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) - May 14, 2013
P1, N=30, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Initiation date: Oct 2006 --> Feb 2007
- Trial termination: Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant (clinicaltrials.gov) - May 10, 2013
P1, N=252, Terminated, Sponsor: Vanderbilt-Ingram Cancer Center
Initiation date: Oct 2006 --> Feb 2007 Completed --> Terminated; study closed prematurely upon PI's departure from VICC
- melphalan / Generic mfg., amifostine / Generic mfg.
Trial completion: Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect (clinicaltrials.gov) - Apr 24, 2013
P1/2, N=25, Completed, Sponsor: University of Kentucky
Completed --> Terminated; study closed prematurely upon PI's departure from VICC Active, not recruiting --> Completed
- arsenic trioxide / Generic mfg.
Enrollment change, Metastases: Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors (clinicaltrials.gov) - Apr 15, 2013
P2, N=22, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed N=120 --> 22
- topotecan / Generic mfg.
Trial completion, Surgery: Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery (clinicaltrials.gov) - Apr 2, 2013
P1, N=26, Completed, Sponsor: Steven Waggoner, MD
N=120 --> 22 Active, not recruiting --> Completed